Ovid Therapeutics, Inc. (OVID)
2.20
-0.14
(-5.98%)
USD |
NASDAQ |
Nov 20, 16:00
2.205
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics EPS Diluted (Quarterly) : -0.1024 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.1024 |
| June 30, 2026 | -0.076 |
| March 31, 2026 | -0.1248 |
| December 31, 2025 | 0.1183 |
| September 30, 2025 | -0.171 |
| June 30, 2025 | -0.0659 |
| March 31, 2025 | -0.1441 |
| December 31, 2024 | -0.1303 |
| September 30, 2024 | -0.1973 |
| June 30, 2024 | 0.1202 |
| March 31, 2024 | -0.1654 |
| December 31, 2023 | -0.2168 |
| September 30, 2023 | -0.1593 |
| June 30, 2023 | -0.1759 |
| March 31, 2023 | -0.1895 |
| December 31, 2022 | -0.1632 |
| September 30, 2022 | -0.1699 |
| June 30, 2022 | -0.2072 |
| March 31, 2022 | -0.229 |
| December 31, 2021 | -0.369 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.1676 |
| June 30, 2021 | -0.2328 |
| March 31, 2021 | 2.532 |
| December 31, 2020 | -0.3442 |
| September 30, 2020 | -0.2765 |
| June 30, 2020 | -0.4056 |
| March 31, 2020 | -0.3661 |
| December 31, 2019 | -0.3453 |
| September 30, 2019 | -0.432 |
| June 30, 2019 | -0.3375 |
| March 31, 2019 | -0.455 |
| December 31, 2018 | -0.5236 |
| September 30, 2018 | -0.5262 |
| June 30, 2018 | -0.53 |
| March 31, 2018 | -0.5357 |
| December 31, 2017 | -0.45 |
| September 30, 2017 | -0.38 |
| June 30, 2017 | -0.57 |
| March 31, 2017 | -1.350 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
| Savara, Inc. | -0.1691 |
| Arrowhead Pharmaceuticals, Inc. | -3.029 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.78M |
| Total Expenses (Quarterly) | 20.78M |
| Enterprise Value | 290.94M |
| Earnings Yield | -8.40% |
| Normalized Earnings Yield | -0.2227 |